These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 30171687)
1. Autoantibodies undetectable by chemiluminescent enzyme immunoassay require extended antigen-antibody reaction time for detection. Mai Y; Ujiie H; Higashi T; Yamagami J; Iwata H; Shimizu H Br J Dermatol; 2019 Jan; 180(1):215-216. PubMed ID: 30171687 [No Abstract] [Full Text] [Related]
2. Chemiluminescent enzyme immunoassay failed to detect anti-desmoglein 3 antibodies in a case of pemphigus vulgaris. Mai Y; Ujiie H; Nishimura M; Koga H; Maya Y; Shiba-Tokuchi K; Fujita Y; Iwata H; Mikawa Y; Shimizu H J Dermatol; 2017 Oct; 44(10):e242-e243. PubMed ID: 28623875 [No Abstract] [Full Text] [Related]
3. Validation of chemiluminescent enzyme immunoassay in detection of autoantibodies in pemphigus and pemphigoid. Fujio Y; Kojima K; Hashiguchi M; Wakui M; Murata M; Amagai M; Yamagami J J Dermatol Sci; 2017 Mar; 85(3):208-215. PubMed ID: 28012821 [TBL] [Abstract][Full Text] [Related]
4. Pemphigus Herpetiformis With Autoantibodies to Desmoglein 1 and 3. Galvañ-Pérez Del Pulgar JI; Tercedor-Sánchez J; Jiménez-Gallo D; Linares-Barrios M Actas Dermosifiliogr; 2016 Nov; 107(9):785-786. PubMed ID: 27340117 [No Abstract] [Full Text] [Related]
5. Cutaneous type of pemphigus vulgaris. Gheisari M; Shahidi-Dadras M; Nasiri S; Dargah SM; Dadkhahfar S; Abdollahimajd F J Am Acad Dermatol; 2020 Sep; 83(3):919-920. PubMed ID: 31931088 [No Abstract] [Full Text] [Related]
6. Pemphigus vulgaris relapsed with serological shift from single-positive desmoglein-3 antibodies to single-positive desmoglein-1 antibodies. Takahagi S; Matsuo Y; Kanamoto M; Kawamoto I; Ishii N J Dermatol; 2024 Jun; 51(6):e198-e200. PubMed ID: 38212901 [No Abstract] [Full Text] [Related]
7. Rapid transition from pemphigus vulgaris to pemphigus foliaceus. Ito T; Moriuchi R; Kikuchi K; Shimizu S J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):455-7. PubMed ID: 25376758 [No Abstract] [Full Text] [Related]
8. A case of pemphigus herpetiformis with absence of antibodies to desmogleins 1 and 3. Miura T; Kawakami Y; Oyama N; Ohtsuka M; Suzuki Y; Ohyama B; Hashimoto T; Motoki Y; Yamamoto T J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):101-3. PubMed ID: 20050294 [No Abstract] [Full Text] [Related]
9. Detailed profiling of anti-desmoglein autoantibodies identifies anti-Dsg1 reactivity as a key driver of disease activity and clinical expression in pemphigus vulgaris. Naseer SY; Seiffert-Sinha K; Sinha AA Autoimmunity; 2015 Jun; 48(4):231-41. PubMed ID: 25384535 [TBL] [Abstract][Full Text] [Related]
10. Enzyme-linked immunosorbent assay as a helpful diagnostic tool for pemphigus erythematosus with equivocal histologic and immunofluorescent findings. Desai A; Harris J; Motaparthi K Dermatol Online J; 2018 Aug; 24(8):. PubMed ID: 30677852 [TBL] [Abstract][Full Text] [Related]
11. Case of pemphigus herpetiformis with immunoglobulin G autoantibodies against desmocollin-3. Ansai O; Shimomura Y; Fujimoto A; Sakai A; Tsuchida Y; Hayashi R; Shigehara Y; Hama N; Abe R J Dermatol; 2017 Jan; 44(1):104-105. PubMed ID: 27177601 [No Abstract] [Full Text] [Related]
12. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris]. Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274 [TBL] [Abstract][Full Text] [Related]
13. Salivary Samples for the Diagnosis of Pemphigus vulgaris Using the BIOCHIP Approach: a Pilot Study. Russo I; Saponeri A; Michelotto A; Alaibac M In Vivo; 2017 Jan; 31(1):97-99. PubMed ID: 28064226 [TBL] [Abstract][Full Text] [Related]
14. Desmoglein ELISA in the diagnosis of pemphigus and its correlation with the severity of pemphigus vulgaris. Mortazavi H; Shahdi M; Amirzargar AA; Naraghi ZS; Valikhani M; Daneshpazhooh M; Vasheghani-Farahani A; Sedaghat M; Chams-Davatchi C Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):53-6. PubMed ID: 19279360 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of anti-desmoglein-1 and anti-desmoglein-3 autoantibody titers in pemphigus patients at the time of the initial diagnosis and after clinical remission. Russo I; De Siena FP; Saponeri A; Alaibac M Medicine (Baltimore); 2017 Nov; 96(46):e8801. PubMed ID: 29145342 [TBL] [Abstract][Full Text] [Related]
16. Herpetiform pemphigus with anti-Dsg 1 and full-length BP180 autoantibodies. Kurashige Y; Mitsuhashi Y; Saito M; Fukuda S; Hashimoto T; Tsuboi R Eur J Dermatol; 2012; 22(2):269-70. PubMed ID: 22265805 [No Abstract] [Full Text] [Related]
17. Frequency of shifts over time in the profile of antidesmoglein antibodies in pemphigus vulgaris. Weitz D; Bystryn JC Arch Dermatol; 2007 Aug; 143(8):1073-4. PubMed ID: 17709673 [No Abstract] [Full Text] [Related]
18. Switching from pemphigus vulgaris to psoriasis: a rare report of three cases. Balighi K; Daneshpazhooh M; Mahmoudi H; Tavakolpour S Int J Dermatol; 2020 May; 59(5):e144-e146. PubMed ID: 32073149 [No Abstract] [Full Text] [Related]
19. Clinical significance of anti-desmoglein-1 and -3 circulating autoantibodies in Pemphigus Patients Measured by Area Index and Intensity Score. Patsatsi A; Kyriakou A; Giannakou A; Pavlitou-Tsiontsi A; Lambropoulos A; Sotiriadis D Acta Derm Venereol; 2014 Mar; 94(2):203-6. PubMed ID: 23995461 [TBL] [Abstract][Full Text] [Related]
20. Immunoserological analyses of 55 patients with pemphigus at the Dermatological Department of Kurume University Hospital: an 11-year retrospective study (1996-2006). Ishii N; Maeyama Y; Karashima T; Nakama T; Kusuhara M; Yasumoto S; Hashimoto T Int J Dermatol; 2008 Dec; 47(12):1321-2. PubMed ID: 19126032 [No Abstract] [Full Text] [Related] [Next] [New Search]